A Multicenter Study to Determine the Safety and Efficacy of NT-501 Utilizing the Medica Membrane in Macular Telangiectasia Type 2
Research Grant
Awarded By
Neurotech Pharmaceuticals, Inc.
Start Date
April 15, 2024
End Date
August 31, 2026
Awarded By
Neurotech Pharmaceuticals, Inc.
Start Date
April 15, 2024
End Date
August 31, 2026